Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
February 19 2021
March 23-26th 2021 : Defymed is happy to announce its participation in the SFD (French diabetes soci...
January 20 2021
February 3-5th 2021 : Defymed is very happy to announce its participation in the EAHAD (European Ass...